41 results on '"Greengard, Judith"'
Search Results
2. Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
3. Engineering Goals for Future Thoracic Endografts—How Can We Make Them More Effective?
4. A Viral Long Terminal Repeat in the Interleukin 2 Gene of a Cell Line That Constitutively Produces Interleukin 2
5. Elucidating the Structural Chemistry of Glycosaminoglycan Recognition by Protein C Inhibitor
6. Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema
7. Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates
8. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg to Gln mutation in the gene for factor V
9. High molecular weight kininogen receptor
10. Brief Report: Variability Of Thrombosis Among Homozygous Siblings With Resistance To Activated Protein C Due To An Arg given to gln Mutation In The Gene For Factor V
11. Protein C Inhibitor Is Expressed in Tubular Cells of Human Kidney
12. Activated protein C resistance caused by Arg506Gln mutation in factor Va
13. Factors Affecting Long-Term Expression of a Secreted Transgene Product after Intravenous Administration of a Retroviral Vector
14. Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High Titer
15. Exonic polymorphisms in the protein C gene: interethnic comparison between Caucasians and Asians
16. Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy
17. ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates
18. Analysis of Testes and Semen from Rabbits Treated by Intravenous Injection with a Retroviral Vector Encoding the Human Factor VIII Gene: No Evidence of Germ Line Transduction
19. Genetic Induction of a Releasable Pool of Factor VIII in Human Endothelial Cells
20. The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent
21. Animal Testing of Retroviral-Mediated Gene Therapy for Factor VIII Deficiency
22. A Two-Allele Polymorphism in Protein C Inhibitor with Varying Frequencies in Different Ethnic Populations
23. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V
24. Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding Sites
25. Activated Protein C Resistance: Molecular Mechanisms
26. Characterization of a cDNA for Rhesus Monkey Protein C Inhibitor – Evidence for N-Terminal Involvement in Heparin Stimulation
27. Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V
28. Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen
29. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three-dimensional molecular modelling of mutations of the protease domain
30. Possible Structural Implications of 20 Mutations in the Protein C Protease Domain
31. Protein S, an Antithrombotic Factor, Is Synthesized and Released by Neural Tumor Cells
32. Use of a Generally Applicable Tissue Factor-Dependent Factor V Assay toDetect Activated Protein C-Resistant Factor Va in Patients ReceivingWarfarin and in Patients With a Lupus Anticoagulant
33. Animal Testing of Retroviral-Mediated Gene Therapy for Factor VIII Deficiency
34. A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen
35. Receptors for high molecular weight kininogen on stimulated washed human platelets
36. Effect Of Two Soluble "Activators" On The Activity Of Factor XII And Factor XIIa (Hageman Factor)
37. Binding of coagulation factor XI to washed human platelets
38. Activated Protein C Resistance: Molecular Mechanisms Based on Studies Using Purified Gln506-Factor V
39. Venous Thromboembolism Associated With Double Heterozygosity for R506Q Mutation of Factor V and for T298M Mutation of Protein C in a Large Family of a Previously Described Homozygous Protein C-Deficient Newborn With Massive Thrombosis
40. Effect Of Two Soluble "Activators" On The Activity Of Factor XII And Factor XIIa (Hageman Factor)
41. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln 506-factor V
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.